Articles tagged with Liver Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Cancer is the leading cause of death among Hispanic Texans under 76, with lower rates of breast and colon cancer screenings. Despite advanced cancer stages at diagnosis, Hispanics experience higher survival rates than non-Hispanic whites.
Researchers developed a test that can clearly distinguish early liver cancer cells from normal liver cells by giving them a distinctive red-brown hue. The test uses a probe to detect and stain a microRNA called mir-21, which is found in liver cancer but not healthy liver cells.
A team of Singaporean and Taiwanese scientists have discovered that Aristolochic Acid (AA), a natural compound found in traditional Asian herbal remedies, is the most potent carcinogen identified to date, causing extensive DNA mutations. The study also reveals AA's possible link to liver cancer and calls for increased public awareness ...
A cohort study published in JNCI found a statistically significant elevated standardized incidence ratio for primary liver cancer among workers exposed to trichloroethylene. However, no significant risk was observed for kidney cancer or non-Hodgkin lymphoma. The authors suggest that further research is needed to confirm these findings.
Researchers found a key role for chaperones in protein assembly and regulation of the proteasome's functionality. The study may reveal new targets for anticancer drugs and advance research on Parkinson's and Huntington's diseases.
A randomized trial found that home-based health education increased HBV screening rates and knowledge about the disease among Hmong Americans, overcoming cultural and language barriers. The study suggests using lay health workers to improve access to screenings and diagnoses.
Research suggests that monitoring hepatic function with HIDA SPECT prior to and during radiation therapy can help tailor treatment plans for unresectable liver cancer patients. This assessment method allows for personalized radiation doses while minimizing the risk of liver injury.
Researchers at Johns Hopkins Medicine developed a method to track liver tumors' response to chemotherapy using paired CT scans, allowing for immediate feedback on treatment effectiveness. This technique has the potential to save patients from delayed diagnosis and reduced treatment efficacy.
Researchers at UNC discovered that the hepatitis C virus binds with microRNA miR-122 to protect itself, promoting viral replication. This interaction presents a promising target for new drugs to treat the infection.
A parasitic worm, prevalent in Southeast Asia, is believed to cause infections that contribute to liver cancer. The grant-funded research aims to understand how the worm's granulin secretion enhances tumorigenic environments and may lead to the development of a treatment.
A study found that enzyme levels in routine blood tests are a better predictor of liver cancer risk than hepatitis infection or other factors. The research used data from over 428,000 people and predicted 91% of liver cancer cases.
Researchers at the University of Southampton will investigate manipulating natural killer cells to attack hepatocellular cancer (HCC) cells. The study aims to create a method for clinical trials using NK cells for immunotherapy, with potential for improving treatment outcomes for HCC patients.
Researchers have deciphered how a stress-inducible gene regulator, AP-1, controls the survival of liver tumor-initiating cells. Altering these proteins in mice impaired liver cancer development, providing new insights into liver cancer initiation.
A study published in Cancer Research identified a gene that disrupts the inflammatory process implicated in liver cancer. Laboratory mice bred without this gene lacked pro-inflammatory protein TREM-1 and protected themselves from developing liver cancer after exposure to carcinogens.
Researchers at Ohio State University found that liver cancer cells lose the ability to produce glucose due to microRNA-23a overexpression. Suppressing miR-23a might reverse this process and offer a new treatment for hepatocellular carcinoma, the most common form of liver cancer.
A new study published in the journal Stem Cell reveals an antibody developed by researchers can detect stem cells in organs like the liver and pancreas. This breakthrough helps understand tissue regeneration and cancer diagnosis and treatment.
A recent study published in the Journal of the National Cancer Institute found that high vitamin E intake from diet or supplements is associated with lower liver cancer risk. The analysis included 132,837 individuals and showed a clear inverse dose-response relation between vitamin E intake and liver cancer risk.
A large cohort study found that high vitamin E intake from diet or supplements is associated with a lower risk of liver cancer. The study included over 132,000 individuals and analyzed data from two population-based cohort studies conducted in China.
Researchers created a mouse model to study the role of AEG-1 in hepatocellular carcinoma, demonstrating its acceleration of disease progression and angiogenesis. The study paves the way for novel therapies targeting AEG-1.
Dr. Curtis Wray has been awarded a $729,000 grant to study disparities in liver cancer life expectancy among underserved populations. His research aims to identify factors contributing to the lower life expectancy of advanced liver cancer patients in these communities.
A recent study found that Alzheimer's patients who undergo hospitalization are at risk for complications such as delirium, loss of independence, and death. Researchers also highlighted the risks associated with Flavocoxid, a medical food used to treat osteoarthritis, which can cause liver injury in some patients. Additionally, screenin...
Scientists have made a significant breakthrough in understanding the cause of bile duct cancer by identifying several new genes frequently mutated in the disease. The research team discovered mutations in 187 genes using state-of-the-art DNA sequencing, shedding light on the molecular mechanisms of the disease.
A new biomarker has been identified to detect hepatitis B-infected patients at risk of developing liver cancer. Telomere length analysis revealed a significant association between longer telomeres and increased risk of liver cancer in patients with hepatitis B.
Researchers found that metformin reduces the level of glucose and inhibits fatty acid synthesis in mice, resulting in significantly fewer and smaller liver tumors. The drug has been linked to reduced risk of liver cancer in patients with Type II diabetes and obesity.
Wilmot researchers develop first genetically engineered mouse model for Intrahepatic Cholangiocarcinoma (IHCC), a type of bile duct cancer. The model incorporates common mutations in humans and enables testing of potential treatments, accelerating the discovery process.
Cancer tumors' metabolic profiles vary based on genes and tissue origin, necessitating individualized treatment approaches. The metabolome, in addition to the genome, is crucial for predicting metabolic changes and guiding therapy.
Researchers discovered a new commonality of chromosomal aberrations among embryonic cancers, including kidney, skeleton, and liver cancers. This finding could reveal the nature and progression of many different kinds of cancer by identifying patterns of mutation in the genome.
Mice genetically engineered to lack Foxa genes show reversed gender-related incidence of liver cancer, highlighting the protective role of estrogens against liver cancer. The study suggests that genetic markers called SNPs within Foxa binding sites may contribute to increased liver cancer risk in women.
The American Cancer Society's annual report shows a decline in cancer incidence and death rates, particularly among African American men and women. The report also highlights increasing trends in certain cancers, such as pancreatic and liver cancer, which may be linked to obesity and early detection practices.
A new study shows that targeting a specific microRNA, miR-221, can prolong the lives of mice with human liver cancer. The treatment also boosted activity of tumor-suppressor genes in these animals.
Recent Mayo Clinic studies identify risk factors for rising liver cancer cases, including hepatitis C infection and fatty liver disease. The studies suggest that screening for hepatitis C could improve treatment and survival rates for affected populations.
Dana-Farber Cancer Institute researchers have identified a mechanism that triggers inflammation in the liver and transforms normal cells into cancerous ones. They demonstrated that a particular micro-RNA, miR-124, can be harnessed to treat or prevent liver cancer.
Recent studies have uncovered significant limitations in liver cancer screening for patients with cirrhosis, emphasizing the need for enhanced diagnostic procedures. Most patients with cirrhosis prefer surveillance over non-screening, and ultrasonographic screening at different intervals did not improve detection of small liver cancers.
A study found that organ transplant recipients have a doubled cancer risk compared to the general population, with increased risks for various types of malignancies, including non-Hodgkin lymphoma and lung cancer. The increased risk is attributed to immunosuppression and oncogenic viral infections.
Two new studies advance the field of yttrium-90 radioembolization for liver cancer treatment. Researchers successfully modified blood vessels to maximize tumor-killing material delivery and simplify treatment. This technique allows for high local radiation doses with minimal risk to healthy tissues.
A new study reveals liver cancer incidence rates are rising in North America and Oceania, while declining in some Asian countries. Despite this, liver cancer remains a significant health issue in these regions, with high rates of infection and limited effective treatments.
Researchers tested a combination of oral drug sorafenib and microbead chemotherapy directly into tumors in advanced liver cancer patients. The treatment showed promise with no increased side effects compared to existing therapies.
Researchers at the University of Hawaii Cancer Center and The Queen's Medical Center will analyze gene expression and imaging data to detect liver cancer earlier. They aim to improve patient outcomes and reduce deaths from this deadly disease.
Researchers found that saffron significantly reduced the number and incidence of liver nodules, with complete inhibition observed at the highest dose. Saffron also inhibited the elevation of proteins indicating liver damage and blocked inflammation.
Inhibiting heat shock transcription factor 1 (HSF1) prevents liver cancer in mice by reducing access to glucose and lipids, which are critical for tumor growth. This finding supports the idea that altering metabolism can be an effective cancer treatment.
A new imaging technology reveals that metabolic shifts in cancer cells occur even before detectable tumors form, suggesting an early diagnostic tool for liver cancer. The study also shows that tumor metabolism changes precede tumor regression, offering potential strategies for cancer treatment and more effective therapies.
Leeds researchers investigate the effectiveness of pure Eicosapentaenoic Acid (EPA) in preventing the spread of bowel cancer to the liver. Previous studies have shown that EPA may prevent large bowel polyps, a precursor to colorectal cancer.
Researchers discover that celecoxib triggers liver cancer cell death by inhibiting a key protein, and combining it with chemotherapy drugs boosts effectiveness. The study suggests the possibility of a new treatment approach for liver cancer, which has a low five-year survival rate.
A recent study published in Gastroenterology highlights the increased risk of gastrointestinal complications in childhood cancer survivors after therapy. Risks for colostomy/ileostomy, cirrhosis or liver biopsy were highest among older patients and those exposed to abdominal radiation or certain chemotherapy treatments.
Boulton's research highlights include discovering key genes and enzymes involved in DNA repair mechanisms, including RTEL1 and ALC1. His work has led to novel therapeutic approaches for cancer treatment, particularly liver cancer.
The number of AIDS-defining cancers decreased, while non-AIDS-defining cancers increased significantly between 1991-2005. Lung cancer emerged as the most common malignancy in people with HIV but not AIDS.
Researchers found that individuals with metabolic syndrome are at higher risk for developing liver cancers, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma. The study, presented at the AACR 102nd Annual Meeting, highlights the importance of metabolic syndrome in increasing liver cancer incidence.
A study found that diabetes is associated with a lower risk of prostate cancer in men, but a higher risk of other cancers and mortality in both men and women. Diabetes was linked to increased risks for colon, rectal, and liver cancers in men and women.
A four-year study confirms that Y-90 radioembolization is a safe and effective treatment for patients with metastatic liver cancer, particularly those who have failed chemotherapy. The procedure preserves patient quality of life and extends life, while also demonstrating anti-tumoral effects.
Researchers at VCU Massey Cancer Center have discovered a novel mechanism in gene regulation that contributes to the development of liver cancer. AEG-1 and SND1 proteins were found to increase RISC activity, leading to increased tumor growth. Inhibiting SND1 is proposed as a potential new avenue for treating liver cancer.
A study at Cold Spring Harbor Laboratory has identified a therapeutic target for liver cancer using a monoclonal antibody that blocks the activity of the FGF19 gene. This approach shows promise in treating patients with FGF19 amplification, which can be used as a biomarker to predict treatment effectiveness.
A long-term study found that consuming three or more drinks a day is associated with an increased risk of pancreatic cancer death in both men and women. Heavy drinking, specifically liquor consumption, also shows a significant association with pancreatic cancer mortality, particularly among never smokers.
A new study found that black patients with early-stage liver cancer have a higher mortality rate than white patients, with median survival times ranging from 8-10 months. The disparity in treatment access also affects the survival rates of Hispanic and black patients compared to white patients.
A recent study found racial disparities in liver cancer survival rates, with black patients experiencing higher mortality rates compared to white and Hispanic patients. Despite receiving similar treatments, black patients had a 12% increased rate of death, indicating poor access to care and subpar treatment outcomes.
Groopman's research identified the link between environmental carcinogens and liver cancer, providing new prospects for prevention in high-risk populations worldwide. His work elucidated the role of aflatoxins in inducing hepatocellular carcinoma, a major cause of mortality in developing countries.
Researchers have found a synthetic molecule, LLL12, that blocks activation of the oncogene STAT3 in liver cancer cells, halting their survival and increasing sensitivity to chemotherapy. This discovery offers potential for an anti-cancer therapy option.
The study found significant disparities in survival rates among Asian-Americans diagnosed with liver cancer, with Laotian/Hmong-Americans having the lowest median survival rate of just one month. The group was also least likely to receive treatment, such as liver transplantation, due to late-stage diagnoses.
Researchers at Columbia University have found that ROCK2 may be a good therapeutic target for treating autoimmune disorders, while targeting CD13+ CSCs in liver cancer could provide a new treatment approach. Additionally, scientists at Stanford University developed ways to enhance RNAi efficacy and persistence while decreasing toxicity.
A case report describes a rare instance of intrahepatic clear cell cholangiocarcinoma, highlighting its distinct characteristics and low risk of metastasis. The cancer's unique cell structure and lack of mucin production set it apart from conventional HCCs.
A study published in Hepatology found that fewer than 20% of patients with cirrhosis and hepatocellular carcinoma received regular surveillance. Despite high-risk patients being recommended for HCC surveillance, population-based studies indicate only 11% are diagnosed early enough to receive potentially curative treatments.